Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CENTAURUS: Rosuvastatin vs Atorvastatin in Acute Coronary Syndrome
NCT00665834Phase 4Completed
- Sponsor
- Queen's University
- Start
- Apr 2006
- Primary completion
- Sep 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of rosuvastatin in acute coronary syndrome (ACS) and dyslipidemia (3 arms), sponsored by Queen's University. Primary endpoint: Apolipoprotein B to Apolipoprotein A ratio at 3 months. Started Apr 2006; status: completed.
02
Drugs
rosuvastatin
03
Conditions
acute coronary syndrome (ACS)dyslipidemia
Beyond the preview
Go deeper on NCT00665834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00665834.